Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation
The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients
Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas
Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia
Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation
A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation
T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate
Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels
Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia
Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient
Donor origin of Graves disease in a BMT recipient: evidence from FISH studies of thyroid tissue
Pertussis: should we vaccinate post transplant?
Second donation of bone marrow: results from the Japan Marrow Donor Program (JMDP)
Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma: successful treatment with high-dose intravenous immunoglobulin
Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation
Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia
Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years
Iron-overload in long-term survivors of hematopoietic transplantation
Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency
Myelodysplastic syndromes. Clinical and biological advances